Announcement

Collapse
No announcement yet.

Neratinib's effect over placebo in HER2+ breast cancer treatment was significant in patients with PIK3CA-altered tumors but not PIK3CA wild-type tumors - April 2009

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
Working...
X